Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp147 | Paediatric Endocrinology & Development | ECE2016

Prenatal metformin treatment prevents estradiol increase and partially improves ovarian function in offspring of obese mothers

Alvarez Daniela , Olguin Sofia , Ceballo Karina , Martinez Jonathan , Cerda Tania , Fernandois Daniela , Cruz Gonzalo

Obesity epidemic is one of the major concerns in the world. Worryingly, a high percentage of pregnant women have obesity, which could imply several consequences. Maternal obesity leads to different abnormalities in pregnancy and delivery. In addition, recent studies show that the offspring of obese mothers has an increased probability to suffer cardiovascular, metabolic and reproductive diseases. We have previously demonstrated that exposure to a high fat diet is related to ob...

ea0038p60 | Clinical practice/governance and case reports | SFEBES2015

Sodium–glucose co-transporter 2 inhibitor associated normoglycaemic ketoacidosis

Bobart Shane , Gleason Benjamin , Schroeder Jonathan , Martinez Nydia , Norris Keith , Williams Sandra

Sodium–glucose co-transporter 2 (SGLT2)-inhibitors represent a new class of drugs that inhibit glucose re-uptake in the proximal renal tubule resulting in glycosuria, with concomitant weight loss and improved glycaemic control in patients with type 2 diabetes mellitus (T2DM). Since becoming available, SGLT2 inhibitors have been implicated in over 20 reported cases of diabetic ketoacidosis or ketosis. In many cases there was an antecedent period of decreased oral intake, a...